<DOC>
	<DOCNO>NCT01758913</DOCNO>
	<brief_summary>Pharmacological closure ductus arteriosus prostaglandin ( PG ) inhibitor use year . Previous study indicate ibuprofen similar effect ductal closure indomethacin less adverse effect renal function , cerebral blood flow mesenteric blood flow.1-7 There , however , study do specifically extremely low birth weight ( ELBW ) infant &lt; 1000 g. This group infants immature kidney often poor response PG inhibitor high mortality morbidity . We hypothesize , ELBW infant , ductal renal response PG inhibitor may different indomethacin ibuprofen .</brief_summary>
	<brief_title>Closure Patent Ductus Arteriosus With Indomethacin Ibuprofen Extreme Low Birth Weight Infants</brief_title>
	<detailed_description>The aim study compare efficacy , side effect renal prostaglandin ( PG ) excretion indomethacin ibuprofen extremely low birth weight ( ELBW ) infant . We enrol one hundred ten ELBW infant clinically significant echo-evidence patent ductus arteriosus assign 2 group , 56 receive indomethacin ( 0.2 mg/kg , 0.1 mg/kg 0.1 mg/kg 24 hour interval ) 54 receive ibuprofen ( 10 mg/kg , 5mg/kg 5 mg/kg 24 hour interval ) . Serum electrolytes , creatinine , renal function ( urine output , glomerular filtration rate ( GFR ) , fractional excretion sodium potassium , osmolar clearance free water clearance ) , urinary PG excretion , pulmonary outcome mortality evaluate .</detailed_description>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>The selection criterion : ( 1 ) preterm infant birth weight &lt; 1000 g ; 2 ) radiographic diagnosis respiratory distress syndrome ( RDS ) ; ( 3 ) requirement mechanical ventilation ( 4 ) echocardiographic clinical evidence significant patent ductus arteriosus ( PDA ) . Exclusion criterion include : ( 1 ) evidence infection sepsis ; 2 ) lethal congenital anomaly ; ( 3 ) oliguria ( &lt; 1 ml/kg/h ) and/or serum creatinine &gt; 2.0 mg/dl ( 4 ) low platelet count ( &lt; 50,000/mm3 ) bleeding tendency .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Bronchopulmonary dysplasia</keyword>
	<keyword>patent ductus arteriosus</keyword>
	<keyword>prostaglandin</keyword>
	<keyword>Respiratory distress syndrome</keyword>
</DOC>